Europe Medical Enzymes Market Forecast 2022-2030

The Europe medical enzymes market is evaluated to grow with a CAGR of 5.86% during the forecasted period of 2022 to 2030. Key factors strengthening the regional market's growth are the increasing demand for enzymes in the pharmaceutical sector, the rise in research and development activities, and the growing need for nutraceuticals and dietary supplements following the COVID-19 pandemic.

MARKET INSIGHTS

The Europe medical enzymes market growth evaluation encompasses a detailed assessment of the United Kingdom, Poland, Belgium, Germany, France, Italy, and Rest of Europe. According to industry estimates, France spent more than 11% of its gross domestic product (GDP) on healthcare. Moreover, according to the Organisation for Economic Co-operation and Development (OECD), cancer was the leading cause of death in the country, accounting for 28.5% of all fatalities in 2014, followed by cardiovascular diseases. In this regard, the rise in alcohol and tobacco consumption is the major cause of diseases in France. As a result, the application of enzymes for treating various conditions and diseases is a key driver of the market's growth in the country.

On the other hand, Italy is one of the first countries to introduce advanced therapies into the European market. With the increase in research in advanced therapies as well as diagnosis, the Italian biotech industry is experiencing rapid expansion. Moreover, investments in research and vaccines have increased in the country, as well. Therefore, the aforementioned factors are expected to propel the Europe medical enzymes market growth over the forecasting years.

COMPETITIVE INSIGHTS

Eminent firms operating in the market include: BBI Solutions, Sanofi, BASF, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 46204

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASED INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES
- 3.1.2. WIDENING APPLICATION IN MEDICAL INDUSTRY
- 3.1.3. GROWING PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION
3.2. KEY RESTRAINTS
- 3.2.1. HANDLING AND SAFETY OF ENZYMES
- 3.2.2. REGULATIONS FOR MEDICAL ENZYMES

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
- 4.6.1. RESEARCH AND DEVELOPMENT
- 4.6.2. OPERATIONS
- 4.6.3. OUTBOUND LOGISTICS
4.7. KEY BUYING CRITERIA
- 4.7.1. COST
- 4.7.2. QUALITY
- 4.7.3. APPLICATION
4.8. REGULATORY FRAMEWORK

5. MARKET BY TYPE

5.1. HYDROLASE
- 5.1.1. HYALURONIDASE
- 5.1.2. LYSOZYMES
- 5.1.3. OTHER HYDROLASES ENZYMES
5.2. THROMBOLYTIC
- 5.2.1. STREPTOKINASE
- 5.2.2. UROKINASE
- 5.2.3. OTHER THROMBOLYTIC ENZYMES
5.3. DIGESTIVE ENZYME
- 5.3.1. LACTASE
- 5.3.2. L-ASPARAGINASE
- 5.3.3. OTHER DIGESTIVE ENZYMES
5.4. ENDONUCLEASE
- 5.4.1. BENZONASE
- 5.4.2. OTHER ENDONUCLEASES

6. MARKET BY APPLICATION

6.1. DISEASE TREATMENT
6.2. DIAGNOSTIC TOOLS
6.3. BIOMEDICAL RESEARCH
6.4. OTHER APPLICATIONS

7. GEOGRAPHICAL ANALYSIS

7.1. EUROPE
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. KEY GROWTH ENABLERS
- 7.1.3. KEY CHALLENGES
- 7.1.4. KEY PLAYERS
- 7.1.5. COUNTRY ANALYSIS
  - 7.1.5.1. UNITED KINGDOM
  - 7.1.5.2. GERMANY
  - 7.1.5.3. FRANCE
  - 7.1.5.4. ITALY
  - 7.1.5.5. BELGIUM
  - 7.1.5.6. POLAND
  - 7.1.5.7. REST OF EUROPE

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
- 8.2.1. ADVANCED ENZYMES
- 8.2.2. AMANO ENZYME
- 8.2.3. BASF
- 8.2.4. BBI SOLUTIONS
- 8.2.5. BRAIN
- 8.2.6. CODEXIS
- 8.2.7. CPC BIOTECH
- 8.2.8. DSM
- 8.2.9. DUPONT
- 8.2.10. NOVOZYMES
- 8.2.11. NOVUS
- 8.2.12. ROCHE
- 8.2.13. SANOFI
- 8.2.14. SEKISUI
- 8.2.15. THERMO FISHER SCIENTIFIC

Product Code: 46204

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MEDICAL ENZYMES
TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES
TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: EUROPE MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: EUROPE MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: EUROPE MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: EUROPE MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: EUROPE MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: EUROPE MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: EUROPE MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: EUROPE MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: EUROPE MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: EUROPE MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: EUROPE MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: EUROPE MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: EUROPE MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: EUROPE MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: LEADING PLAYERS OPERATING IN EUROPE MEDICAL ENZYMES MARKET
TABLE 20: LIST OF MERGERS & ACQUISITIONS
TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
FIGURE 8: EUROPE MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)
FIGURE 9: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021
FIGURE 10: EUROPE MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)
FIGURE 11: EUROPE MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)
FIGURE 12: EUROPE MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 13: EUROPE MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 14: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021
FIGURE 15: EUROPE MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)
FIGURE 16: EUROPE MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)
FIGURE 17: EUROPE MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 18: EUROPE MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)
FIGURE 19: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021
FIGURE 20: EUROPE MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)
FIGURE 21: EUROPE MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 23: EUROPE MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)
FIGURE 24: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021
FIGURE 25: EUROPE MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)
FIGURE 26: EUROPE MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)
FIGURE 27: EUROPE MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 28: EUROPE MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)
FIGURE 29: EUROPE MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)
FIGURE 30: EUROPE MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)
FIGURE 31: EUROPE MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 32: EUROPE MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 33: UNITED KINGDOM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: GERMANY MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: FRANCE MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: ITALY MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: BELGIUM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: POLAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: REST OF EUROPE MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)